Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer

This publication has 22 references indexed in Scilit:

• Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
  Pharmacogenomics, 2002
• Increased expression of mRNAs for microtubule disassembly molecules during nerve regeneration
  Molecular Brain Research, 2002
• Activation Mechanism of Solubilized Epidermal Growth Factor Receptor Tyrosine Kinase
  Biochemical and Biophysical Research Communications, 2002
• Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors
  Cancer Letters, 2001
• Structural requirements for ErbB2 transactivation
  Seminars in Oncology, 2001
• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
  The Lancet, 2001
• Effect of Benzo[a]pyrene Diol Epoxide on Expression of Retinoic Acid Receptor-β in Immortalized Esophageal Epithelial Cells and Esophageal Cancer Cells
  Biochemical and Biophysical Research Communications, 2001
• The EGF receptor family as targets for cancer therapy
  Oncogene, 2000
• Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis
  Carcinogenesis: Integrative Cancer Research, 2000
• Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
  Journal of Clinical Investigation, 1994